The nonsteroidal FXR agonist cilofexor (GS-9674) improves markers of cholestasis and liver injury in patients with PSC.
Michael Trauner,Aliya Gulamhusein,Bilal Hameed,Stephen H. Caldwell,Mitchell L. Shiffman,Charles Landis,Bertus Eksteen,Kosh Agarwal,Andrew J. Muir,Simon M. Rushbrook,Xiaomin Lu,Jun Xu,Jen Chieh Chuang,Andrew N. Billin,Chuhan Chung,Georgia Li,G. Mani Subramanian,Robert P. Myers,Christopher L. Bowlus,Kris V. Kowdley Hepatology(2019)
AI 理解论文
溯源树
样例